-

Fujifilm Highlights Print Embellishment Capabilities at Amplify Print 2025 and IPMA 2025

HANOVER PARK, Ill.--(BUSINESS WIRE)--FUJIFILM North America Corporation, Business Innovation Division, today announced that it will be showcasing the range of embellishment-focused capabilities and solutions that its REVORIA PRESS production press series can achieve at Amplify Print 2025 (Booth #4739), June 10-12 in Rosemont, Illinois. Fujifilm will also be appearing at the In-Plant Printing and Mailing Association (IPMA) Education Conference (Booth #302), June 8-12 in Spokane, Washington.

“In today’s competitive and advanced print landscape, the ability to create quality, eye-catching embellishments is critical,” said Yuji Oki, general manager, FUJIFILM North America Corporation, Business Innovation Division. “As industry leaders we’re always innovating to bring the best quality solutions to the marketplace. Our full line of CMYK+ enabled products demonstrate firsthand how Fujifilm offers the perfect solutions for the complex print jobs our print service providers see every day. We’re excited to demonstrate these capabilities at Amplify Print and IPMA, to show print service providers how they can ‘Make More’ with Fujifilm.”

The REVORIA PRESS™ SC285S (SC285S) will be onsite and running live at Amplify Print 2025. Bringing the high-end capabilities of Fujifilm’s flagship REVORIA PRESS™ PC1120 digital press to a mid-range printing press, the SC285S is equipped with a specialty toner station1 in addition to its four-color toners, enabling five-color printing in one pass. The SC285S and SC285 series presses, with printing speeds of 85 pages per minute, are best suited for quick printing and in-house printing environments. SC285S achieves a compact footprint through Fujifilm’s newly developed Vertical Toner Development Technology, which transports developer from bottom to top against gravity, significantly reducing the size of each development unit, and in turn enabling five-color printing without increasing the machine size. These advancements not only help print service providers’ bottom lines, but give their customers impressive, attention-grabbing results.

As part of the Digital Embellishment track at Amplify Print 2025, Fujifilm’s Andrew Gunn, director of product solutions and enablement for the Americas, will be part of a panel discussion entitled “Driving Demand for 5th and 6th Station Digital Print and Embellishments,” where he will discuss, along with his peers, trends, techniques, and real-world applications of tactile and visual enhancements in print. This panel discussion is scheduled for 9:15AM CT on Wednesday, June 11.

The same week, Fujifilm will also be exhibiting at the IPMA conference, where leaders in in-plant printing and mailing will gather to learn the latest industry advancements. “Our print solutions, especially our REVORIA PRESS™, APEOSPRO, J PRESS, and ACUITY™ series presses, offer a myriad of ways for our in-plant customers to integrate embellishments into their everyday workflows in creative and cost-effective ways,” said Oki. “We’re excited to share our latest developments with IPMA attendees onsite at the event!”

For more information about Fujifilm’s print solutions, visit https://print-us.fujifilm.com.

About Fujifilm

FUJIFILM North America Corporation, a marketing subsidiary of FUJIFILM Holdings America Corporation, consists of six operating divisions. The Imaging Division provides consumer and commercial photographic products and services, including silver halide consumables; inkjet consumables; digital printing equipment, along with service and support; personalized photo products fulfillment; film; one-time-use cameras; and the popular INSTAX® line of instant cameras, smartphone printers, instant film, and accessories. The Electronic Imaging Division markets its GFX System and X Series lines of mirrorless digital cameras, lenses, and accessories to provide a variety of content creation solutions for both still and moving imagery. The Optical Devices Division provides optical lenses for the broadcast, cinematography, closed circuit television, videography, and industrial markets, and also markets binoculars and other optical imaging solutions. The Business Innovation Division offers a full lineup of digital print and toner technologies focused on enabling the digital transformation of businesses and print shops with its offerings of multifunction printers, digital inkjet presses, production toner printers, software, and more. The Industrial Products Division delivers new products derived from Fujifilm technologies including data storage tape products, including OEM and FUJIFILM Ultrium LTO cartridges, desalination solutions, microfilters and gas separation membranes.

For more information, please visit https://www.fujifilm.com/us/en/about/region, go to https://x.com/fujifilmus to follow Fujifilm on X, or go to www.facebook.com/FujifilmNorthAmerica to Like Fujifilm on Facebook.

FUJIFILM Corporation is a subsidiary of FUJIFILM Holdings Corporation. FUJIFILM Holdings Corporation, headquartered in Tokyo, leverages its depth of knowledge and proprietary core technologies to deliver innovative products and services across the globe through the four key business segments of healthcare, electronics, business innovation, and imaging with over 70,000 employees. Guided and united by our Group Purpose of “giving our world more smiles,” we address social challenges and create a positive impact on society through our products, services, and business operations. Under its medium-term management plan, VISION2030, which ends in FY2030, we aspire to continue our evolution into a company that creates value and smiles for various stakeholders as a collection of global leading businesses and achieve a global revenue of 4 trillion yen (29 billion USD at an exchange rate of 140 JPY/USD). For more information, please visit: www.fujifilmholdings.com.

For further details about our commitment to sustainability and Fujifilm’s Sustainable Value Plan 2030, click here

FUJIFILM, ACUITY, and REVORIA PRESS are trademarks of FUJIFILM Corporation and its affiliates.

© 2025 FUJIFILM North America Corporation and its affiliates. All rights reserved.

1 Clear, pink, gold, silver and white for specialty toners. Availability of gold, silver and white will be announced soon.

Contacts

Daniel Carpenter
FUJIFILM Holdings America Corporation
daniel.carpenter@fujifilm.com
914-529-2417

FUJIFILM North America Corporation


Release Versions

Contacts

Daniel Carpenter
FUJIFILM Holdings America Corporation
daniel.carpenter@fujifilm.com
914-529-2417

More News From FUJIFILM North America Corporation

Fujifilm Announces Firmware Roadmap for FUJIFILM GFX ETERNA 55 Filmmaking Camera

TOKYO--(BUSINESS WIRE)--FUJIFILM Corporation today announces a firmware roadmap designed to further expand the applications of the “FUJIFILM GFX ETERNA 55” (GFX ETERNA 55), Fujifilm’s first dedicated filmmaking camera. The latest update expands the possibilities for creative work and further enhances expressive capabilities. Ver.1.101 – Available July 15, 2026 The camera’s overall operational stability and usability have been updated to provide a refined shooting experience. Ver.1.20 or later –...

Fujifilm Adds Second Cinema Power Zoom to GF Lens Lineup: FUJINON GF19-35mmT3.5 PZ OIS WR

VALHALLA, N.Y.--(BUSINESS WIRE)--FUJIFILM North America Corporation, Electronic Imaging Division, today announced the release of FUJINON GF19-35mmT3.5 PZ OIS WR (“GF19-35mmT3.5”), the second FUJINON cinema power zoom lens for the GFX System. With a native G Mount, GF19-35mmT3.5 provides the widest angle of view available in the GF format, offering filmmakers at all levels of production a large format cinema zoom with expanded cinematic versatility and exceptional optical performance in a compac...

FUJIFILM Biotechnologies Selected in FDA PreCheck Pilot Program to Advance U.S. Drug Manufacturing

HOLLY SPRINGS, N.C.--(BUSINESS WIRE)--FUJIFILM Biotechnologies (Fujifilm), a world-leading contract development and manufacturing organization (CDMO) for biologics, vaccines, and advanced therapies, today announced that its commercial-scale cell culture manufacturing facility in Holly Springs, North Carolina, has been selected as one of only seven participants in the U.S. Food and Drug Administration's (FDA) PreCheck Pilot Program. The program is a strategic initiative designed to strengthen Am...
Back to Newsroom